Sep 6, 2023Pediatric DRV/r (pDRV/r) FAQsThis document is meant to answer some of the most common questions that surround pediatric darunavir/ritonavir 120/20mg (pDRV/r) - a new...
Sep 6, 2023Pediatric DRV/r (pDRV/r) Product ProfileThis product profile provides a clinical overview of the best-in-class protease inhibitor (PI) formulated in a fixed-dose combination...
Jun 5, 2023Pediatric ALD (pALD) FAQsThis document is meant to answer some of the most common questions surround the fixed-dose combination of pediatric...
May 30, 2023pALD Product ProfileThis product profile provides a clinical overview of the fixed-dose combination of pediatric abacavir/lamivudine/ dolutegravir 60/30/5 mg...
Mar 17, 2022CHAI DRV/r 2L Product ProfileA presentation with the latest information on DRV/r (400/50mg) and considerations for adult second line treatment optimization.
Oct 12, 2021CHAI Pediatric DTG Product ProfileThis product profile provides a clinical overview of pediatric DTG, market updates and implementation considerations, and provides...
Aug 1, 2018TLD ResourcesCHAI's TLD resources help countries in creating the best plan for TLD introduction. CHAI TLD Clinical Action Memo CHAI DTG Use In Women...
Aug 1, 2017CHAI TLD Product ProfileThis presentation provides a broad overview of the benefits of DTG-containing regimens, the advantages of fixed-dose combination ARVs,...
Jan 1, 2017CHAI Pediatric LPV/r Oral Pellets Product ProfileThis presentation provides a broad overview of pediatric LPV/r oral pellets, guidance on administration, and key considerations for...